"10.1371_journal.ppat.0030046","plos pathogens","2007-04-06T00:00:00Z","Frank Maldarelli; Sarah Palmer; Martin S King; Ann Wiegand; Michael A Polis; JoAnn Mican; Joseph A Kovacs; Richard T Davey; Diane Rock-Kress; Robin Dewar; Shuying Liu; Julia A Metcalf; Catherine Rehm; Scott C Brun; George J Hanna; Dale J Kempf; John M Coffin; John W Mellors","HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland, United States of America; Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois, United States of America; Lab Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America; Department of Critical Care, National Institutes of Health Clinical Center, National Institutes of Health, Bethesda, Maryland, United States of America; SAIC-Frederick, Frederick, Maryland, United States of America; Division of Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States of America","JMC and JWM conceived and designed the experiments and provided overall project oversight. SP and AW performed the experiments. FM, MSK, AW, JMC, and JWM analyzed the data. RTD, JAM, CR, SCB, GJH, and DJK contributed reagents/materials/analysis tools. FM, MSK, JMC, and JWM wrote the paper. FM provided patient care oversight and managed regulatory affairs. MAP, JM, JAK, RTD, DRK, and SL provided patient care and protocol oversight. JAM provided protocol oversight. SCB, GJH, and DJK provided data analysis and clinical trial oversight.","MSK, SCB, GJH, and DJK are employees of Abbott Laboratories. JWM is a member of the Abbott Scientific Advisory Committee for HIV and hepatitis C virus therapeutics.","2007","04","Frank Maldarelli","FM",18,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
